Northern Trust’s Edesa Biotech EDSA Stock Holding History

Northern Trust’s Portfolio EDSA Stock Details EDSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$78.4K	Buy	+14,994	New	+$45K	﹤0.01%	4159
2023 Q4	–	Sell	-3,220	Closed	-$14.2K	–	4491
2023 Q3	$14.2K	Hold	3,220	–	–	﹤0.01%	4371
2023 Q2	$18.3K	Hold	3,220	–	–	﹤0.01%	4424
2023 Q1	$20.6K	Buy	3,220 +1,027	+47%	+$10.7K	﹤0.01%	4444
2022 Q4	$33.2K	Hold	2,193	–	–	﹤0.01%	4385
2022 Q3	$14K	Hold	2,193	–	–	﹤0.01%	4600
2022 Q2	$25K	Hold	2,193	–	–	﹤0.01%	4585
2022 Q1	$46K	Hold	2,193	–	–	﹤0.01%	4546
2021 Q4	$86K	Hold	2,193	–	–	﹤0.01%	4465
2021 Q3	$113K	Hold	2,193	–	–	﹤0.01%	4370
2021 Q2	$81K	Hold	2,193	–	–	﹤0.01%	4412
2021 Q1	$83K	Buy	+2,193	New	+$88.4K	﹤0.01%	4310

Other funds holding EDSA

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

SRL

Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return

Northern Trust's EDSA Position: Q1 2026 in Review

Northern Trust opened a new position in Edesa Biotech (EDSA) in Q1 2026: 14,994 shares worth $78.4K. The stake represents ﹤0.01% of the portfolio and ranks #4159 among its holdings. This is a return to the name: Northern Trust previously reported a position in EDSA as recently as Q3 2023.

Northern Trust first reported a position in EDSA in Q1 2021 and has held it in 12 quarters since. The position peaked at $113K in Q3 2021. 28 funds tracked by Wall St. Rank hold EDSA as of Q1 2026.

Northern Trust held 14,994 shares of Edesa Biotech worth $78.4K as of Q1 2026.
Edesa Biotech was a new Northern Trust position in Q1 2026.
Edesa Biotech made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #4159 holding.
Northern Trust first reported a position in Edesa Biotech in Q1 2021 and has held it in 12 quarters since.
Northern Trust's Edesa Biotech position peaked at $113K in Q3 2021.
28 funds tracked by Wall St. Rank held Edesa Biotech as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.